These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 4403289)

  • 1. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 2. Actions of levodopa and dopamine in the central nervous system.
    Sourkes TL
    JAMA; 1971 Dec; 218(13):1909-11. PubMed ID: 4398939
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 5. Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat.
    Fibiger HC; Lonsbury B; Cooper HP; Lytle LD
    Nat New Biol; 1972 Apr; 236(68):209-11. PubMed ID: 4401617
    [No Abstract]   [Full Text] [Related]  

  • 6. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.
    Biggs CS; Fowler LJ; Whitton PS; Starr MS
    Eur J Pharmacol; 1996 Mar; 299(1-3):83-91. PubMed ID: 8901010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 8. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term regulation of tyrosine hydroxylase.
    Costa E; Guidotti A; Zivkovic B
    Adv Biochem Psychopharmacol; 1974; 12(0):161-75. PubMed ID: 4154019
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioural studies of the actions of cocaine, monoamine oxidase inhibitors and iminodibenzyl compounds on central dopamine neurones.
    Christie JE; Crow TJ
    Br J Pharmacol; 1973 Jan; 47(1):39-47. PubMed ID: 4577590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a direct action of monamines on the chick central nervous system.
    Spooner CE; Winters WD
    Experientia; 1965 May; 21(5):256-8. PubMed ID: 5294557
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 13. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and neurochemical effects induced by reserpine in mice.
    de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
    Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of DL- -methyltyrosine and L-DOPA on the hyperthermic and behavioral actions of LSD in rabbits.
    Horita A; Hamilton AE
    Neuropharmacology; 1973 May; 12(5):471-6. PubMed ID: 4708475
    [No Abstract]   [Full Text] [Related]  

  • 17. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 18. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.